Ayus JC, et al. Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: A case series. Am J Kidney Dis 2015; 65:435–442. doi: 10.1053/j.ajkd.2014.09.021
Fitts W, et al. The changing face of osmotic demyelination syndrome: A retrospective, observational cohort study. Neurol Clin Pract 2021; 11:304–310. doi: 10.1212/CPJ.0000000000000932
Ambati R, et al. Osmotic demyelination syndrome: Novel risk factors and proposed pathophysiology. Intern Med J (published online ahead of print June 19, 2022). doi: 10.1111/imj.15855; https://onlinelibrary.wiley.com/doi/10.1111/imj.15855
Ayus JC, et al. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med 1987; 317:1190–1195. doi: 10.1056/NEJM198711053171905
Verbalis JG, et al. Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations. Am J Med 2013; 126 (10 Suppl 1):S1–S42. doi: 10.1016/j.amjmed.2013.07.006
Spasovski G, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014; 29 (Suppl 2):i1-i39. doi: 10.1093/ndt/gfu040
MacMillan TE, et al. Osmotic demyelination syndrome in patients hospitalized with hyponatremia. NEJM Evid 2023; 2. https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200215
Ayus JC, Moritz ML. Hyponatremia treatment guidelines—have they gone too far? NEJM Evid 2023;2. https://evidence.nejm.org/doi/full/10.1056/EVIDe2300014
Kinoshita T, et al. Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes. J Crit Care (published online ahead of print May 13, 2023). doi: 10.1016/j.jcrc.2023.154325; https://www.sciencedirect.com/science/article/abs/pii/S0883944123000746?via%3Dihub
Geoghegan P, et al. Sodium correction practice and clinical outcomes in profound hyponatremia. Mayo Clin Proc 2015; 90:1348–1355. doi: 10.1016/j.mayocp.2015.07.014
Krummel T, et al. Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: Results of an observational retrospective study. BMC Nephrol 2016; 17:159. doi: 10.1186/s12882-016-0370-z
Winzeler B, et al. Long-term outcome of profound hyponatremia: A prospective 12 months follow-up study. Eur J Endocrinol 2016; 175:499–507. doi: 10.1530/EJE-16-0500
George JC, et al. Risk factors and outcomes of rapid correction of severe hyponatremia. Clin J Am Soc Nephrol 2018; 13:984–992. doi: 10.2215/CJN.13061117
Woodfine JD, et al. Derivation and validation of a novel risk score to predict overcorrection of severe hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) score. Clin J Am Soc Nephrol 2019; 14:975–982. doi: 10.2215/CJN.12251018
Turkmen E, et al. Factors affecting prognosis of the patients with severe hyponatremia. Nefrologia (Engl Ed) 2022; 42:196–202. doi: 10.1016/j.nefroe.2022.05.002
Mustajoki S. Severe hyponatraemia (P-Na < 116 mmol/l) in the emergency department: A series of 394 cases. Intern Emerg Med 2023; 18:781–789. doi: 10.1007/s11739-023-03221-y
Nagase K, et al. Predictive correction of serum sodium concentration with formulas derived from the Edelman equation in patients with severe hyponatremia. Sci Rep 2023; 13:1783. doi: 10.1038/s41598-023-28380-y
Massop K, et al. NaCl 3% bolus therapy as emergency treatment for severe hyponatremia: Comparison of 100 ml versus 250 ml. J Clin Endocrinol Metab (published online ahead of print February 20, 2023). doi: 10.1210/clinem/dgad080; https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgad080/7048454?redirectedFrom=fulltext&login=false
Moritz ML, Ayus JC. 100 cc 3% Sodium chloride bolus: A novel treatment for hyponatremic encephalopathy. Metab Brain Dis 2010; 25:91–96. doi: 10.1007/s11011-010-9173-2
Moritz ML, Ayus JC. Management of hyponatremia in various clinical situations. Curr Treat Options Neurol 2014; 16:310. doi: 10.1007/s11940-014-0310-9